LifePlan Financial Group, Inc - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 81 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 2,040.10 and the average weighting 1.1%.

Quarter-by-quarter ownership
LifePlan Financial Group, Inc ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$4,000
+33.3%
28,8100.0%0.00%0.0%
Q4 2018$3,000
-57.1%
28,8100.0%0.00%
-50.0%
Q3 2018$7,0000.0%28,8100.0%0.00%0.0%
Q2 2018$7,000
-30.0%
28,8100.0%0.00%
-33.3%
Q1 2018$10,000
-16.7%
28,8100.0%0.01%
-25.0%
Q4 2017$12,0000.0%28,8100.0%0.01%0.0%
Q3 2017$12,000
-20.0%
28,8100.0%0.01%
-20.0%
Q2 2017$15,000
-11.8%
28,8100.0%0.01%
-16.7%
Q1 2017$17,000
-5.6%
28,8100.0%0.01%
-7.7%
Q4 2016$18,000
-30.8%
28,8100.0%0.01%
-27.8%
Q3 2016$26,000
+73.3%
28,8100.0%0.02%
+80.0%
Q2 2016$15,000
-44.4%
28,8100.0%0.01%
-47.4%
Q1 2016$27,000
-28.9%
28,8100.0%0.02%
-29.6%
Q4 2015$38,000
-42.4%
28,8100.0%0.03%
-43.8%
Q3 2015$66,000
+43.5%
28,8100.0%0.05%
+54.8%
Q2 2015$46,0000.0%28,8100.0%0.03%0.0%
Q1 2015$46,000
-14.8%
28,8100.0%0.03%
-13.9%
Q4 2014$54,000
+42.1%
28,8100.0%0.04%
+12.5%
Q3 2014$38,000
-11.6%
28,8100.0%0.03%
+3.2%
Q2 2014$43,000
-18.9%
28,8100.0%0.03%
-26.2%
Q1 2014$53,000
-11.7%
28,8100.0%0.04%
+2.4%
Q4 2013$60,000
-21.1%
28,8100.0%0.04%
-33.9%
Q3 2013$76,000
-1.3%
28,8100.0%0.06%
-27.1%
Q2 2013$77,00028,8100.08%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q3 2015
NameSharesValueWeighting ↓
Platinum Management (NY) LLC 10,375,329$13,549,00019.76%
Catalyst Capital Advisors LLC 790,000$1,635,0000.53%
DSC Advisors, L.P. 500,000$1,035,0000.50%
STONERIDGE INVESTMENT PARTNERS LLC 142,528$295,0000.06%
Hudock, Inc. 30,500$63,0000.05%
BRR OpCo, LLC 52,700$109,0000.05%
TFS CAPITAL LLC 418,074$865,0000.04%
LifePlan Financial Group, Inc 28,810$60,0000.04%
NOMURA HOLDINGS INC 3,831,177$7,947,0000.04%
BOLTON LP 77,400$160,0000.03%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders